Related references
Note: Only part of the references are listed.Update on carbonic anhydrase inhibitors: a patent review (2008-2011)
Mayank Aggarwal et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Structure-based drug discovery of carbonic anhydrase inhibitors
Claudiu T. Supuran
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2012)
Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
Paul C. McDonald et al.
ONCOTARGET (2012)
Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors
Yuanmei Lou et al.
CANCER RESEARCH (2011)
Glycosyl Coumarin Carbonic Anhydrase IX and XII Inhibitors Strongly Attenuate the Growth of Primary Breast Tumors
Nadia Touisni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREXA®) and interferon-alpha-2a in metastatic renal cell carcinoma patients
M. Siebels et al.
WORLD JOURNAL OF UROLOGY (2011)
Carbonic Anhydrase IX as an Anticancer Therapy Target: Preclinical Evaluation of Internalizing Monoclonal Antibody Directed to Catalytic Domain
M. Zatovicova et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy
Alexander B. Stillebroer et al.
EUROPEAN UROLOGY (2010)
Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007-2009
Sally-Ann Poulsen
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Therapeutic Applications of Glycosidic Carbonic Anhydrase Inhibitors
Jean-Yves Winum et al.
MEDICINAL RESEARCH REVIEWS (2009)
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
NATURE REVIEWS DRUG DISCOVERY (2008)
Carbonic anhydrase IX: A new druggable target for the design of antitumor agents
Jean-Yves Winum et al.
MEDICINAL RESEARCH REVIEWS (2008)
Carbonic anhydrase IX inhibitors: fluorescent sulfonamides as therapeutic and diagnostic agents
Jean-Yves Winum
EXPERT OPINION ON THERAPEUTIC PATENTS (2007)
Circulating oncoproteins HER2/neu, EGFR and CAIX (MN) as novel cancer biomarkers
Walter P. Carney
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2007)
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (I-124-cG250) and PET in patients with renal masses: a phase I trial
Chaitanya R. Divgi et al.
LANCET ONCOLOGY (2007)
Carbonic anhydrase inhibitors.: Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors
A Cecchi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX
JR Casey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Share Paper
